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Abstract
Sepsis is a complex condition that is initiated by infection. The incidence of sepsis and 
its severity are higher at an older age (mean age of approximately 65 years). Clinical 
manifestations of sepsis are derived from systemic inflammatory response syndrome. 
Age‐related defects in immunity are shown by changes in cellular and humoral immu‐
nity. Recent studies have shown significant changes in the innate response (e.g., changes 
in toll‐like receptor expression, abnormal activation of mitogen‐activated protein kinases, 
and production of reactive oxygen species) in older people. Transcriptomic analysis on a 
large scale has provided interesting information showing that specific groups of patients 
actually have singular profiles for inflammatory responses. Findings from our research 
group have identified major molecular pathways that are particularly affected in older 
people during sepsis. Oxidative phosphorylation pathways and mitochondrial dysfunc‐
tion are altered the most in older people with sepsis compared with younger patients 
with sepsis. These pathways might have a pivotal role in worsening clinical outcomes 
compared with younger people with sepsis. The mechanisms leading to specific dysfunc‐
tion of several signaling pathways in the immune response of older people are complex 
and appear to involve multiple factors, including environmental factors, microRNAs, 
and epigenetic changes.
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1. Introduction
Sepsis is a complex disease that is triggered by infection and characterized by massive deregula‐
tion of the immune system [1]. Clinical manifestations of sepsis, such as fever, a hypercoagulable 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
state, and peripheral hypotension, are derived from systemic inflammatory response syndrome 
(SIRS). Clinically, SIRS can be classified according to the nature of the symptoms manifested by 
the individual, such as (1) hypothermia or fever, (2) tachycardia, (3) tachypnea, and (4) leuko‐
cytosis or leucopenia [2]. Infection is probably the most common cause of SIRS, associated with 
the action of cytokines that are derived from cells of the immune system acting in organs and 
systems with specific receptors [3]. Figure 1 illustrates the stages of evolution of sepsis using 
SIRS as the standard diagnosis.
Recently, the Journal of the American Medical Association (JAMA) published the “Third 
International Consensus Definitions for Sepsis and Septic Shock (Sepsis‐3).” This is the 
most recent international consensus on diagnostic criteria for sepsis and septic shock. 
According to the new criteria for the diagnosis of sepsis, organ dysfunction promoted by 
the disease must be considered [4]. In this regard, SIRS is no longer used as a diagnostic cri‐
terion for sepsis, and organ dysfunction is represented by an increase of two or more points 
in the Sequential Organ Failure Assessment (SOFA) score. The SOFA score is obtained by 
using a scoring scheme that assigns one to four points. The SOFA score uses variables, 
such as the platelet count, bilirubin, and oxygenation index, using variables as scoring of 
platelet, bilirubin, oxygenation index, use of vasoactive drugs, the Glasgow Coma Scale, 
and creatinine.
Septic patients have an average age of approximately 65 years [5], and the incidence of 
sepsis and its severity are significantly increased at an older age [6, 7]. Factors that con‐
tribute to this increase include defects in the integrity of epithelial barriers, dysfunction in 
the cough reflex, changes in level of consciousness, immobility, comorbidities, presence of 
invasive medical devices, a decrease in physiological reserves, endocrine disorders, and 
malnutrition [8, 9].
Immune defects associated with age are shown by changes in cellular and humoral immunity 
[10]. Aging is associated with an increase in memory T‐cell [9] repertoire and in the responses 
of types 1 and 2 [11, 12]. B cells gradually decrease with age, while the production of immu‐
noglobulin increases [13].
Initial reports described preservation of the innate immune response in older people [14], 
but recent studies have shown significant changes in these components [9]. Studies have 
Figure 1. Evolution of sepsis.
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suggested changes in expression and toll‐like receptor (TLR) function as age advances 
and that this affects the response to pathogens [15]. An increase in the basal levels of 
inflammatory mediators [16, 17], aberrant activation of mitogen‐activated protein kinases 
[18], an increased number of apoptotic cells [19], defects in the process of phagocytosis, 
production of reactive oxygen species (ROS), and deregulation in expression of accessory 
molecules have been reported [20]. Indeed, evidence indicates that older people produce 
higher levels of pro‐inflammatory cytokines, coagulation factors, and acute phase proteins 
in the absence of infection [21–23].
However, the inflammatory response of older people in the presence of a serious infectious 
process remains controversial. Because of the increasing aging population, this issue has 
received great attention from the scientific community (Figure 2). Studies have identified a 
higher mortality, inflammatory response, hypothermia, disseminated intravascular coagula‐
tion, and apoptosis in aged animals undergoing experimental models of sepsis [24]. Aspects 
Figure 2. Population aging around the world. Source: World Health Organization—World report on Ageing and Health 
—2015.
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of immunosenescence and a more intense inflammatory response in aged rodents with sepsis 
have been well characterized [25, 26]. However, intriguingly, clinical studies (including our 
own research group) have detected a similar immune response profile when comparing older 
patients with sepsis with younger patients [27–30].
2. Transcriptomics in sepsis
Transcriptomics is a powerful technique, which can be used for detecting new therapeutic 
biomarkers and targets in the field of infectious diseases [31, 32]. Several studies of gene 
expression in sepsis on a large scale have been performed. These studies have shown persis‐
tent repression of genes of adaptive immunity and massive activation of pathways of innate 
immunity in septic shock [33]. Using RNA obtained from total blood, Wong and colleagues 
[34] identified activation of oxidative phosphorylation, signaling by interleukin (IL)‐10, TLRs, 
TREM, NF‐κB, the protein ubiquitination pathway, and IL‐6 in macrophages. These authors 
also described suppression of specific pathways of T lymphocytes and signaling by chemo‐
kines (CCR5). Similarly, Cvijanovich and colleagues [35] detected activation of TLRs, IL‐10, 
IL‐6, and NF‐κB with concomitant suppression of T lymphocytes. Additionally, they detected 
activation of protein in the acute phase, p38, the complement system, and some nuclear recep‐
tors (LXR and PPAR) in association with repression of antigenic presentation pathways.
Shanley et al. [36] used total blood RNA from septic patients and performed global gene 
expression experiments. Their results agree with those studies described above in many 
aspects, except that they also identified integrin activation, IGF‐1, GM‐CSF, and insulin 
receiver. Tang et al. [37] described activation of apoptosis genes, including CARD12, APAF1, 
and ELMOD2, in mononuclear cells of septic patients. Moreover, a recent study in patients 
with severe blunt trauma described surprisingly similar results with activation of a large 
number of genes involved in inflammation, pattern recognition, and antimicrobial function 
[38]. This study also showed simultaneous repression of genes involved in antigenic presenta‐
tion and proliferation of T cells, suggesting that severe physiological stress, regardless of the 
cause, has similar genetic signatures.
3. Sepsis: a heterogeneous disease
Sepsis affects different groups of patients (e.g., those with an older age, diabetes, nephropathy, 
multiple trauma, surgery, and obesity). Historically, each specific group of patients is thought 
to be present with a characteristic inflammatory response. In the course of sepsis, transition 
of the inflammatory response to standard immunosuppression has been suggested to explain 
the disappointing results obtained by clinical studies that investigated the use of anti‐inflam‐
matory drugs in this population of patients [39–41]. Transcriptomic analysis on a large scale 
has provided interesting information in this regard, showing that specific groups of patients 
actually have singular profiles [42–44]. However, a recently published systematic review was 
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unable to detect distinct pro‐inflammatory and anti‐inflammatory phases in sepsis or differ‐
ences in gene expression when analyzing different sub‐populations [45]. Therefore, this issue 
remains extremely controversial.
To the best of our knowledge, our research group was the first to study characteristics of 
sepsis in older people through transcriptomics analysis on a large scale [46]. We detected 388 
genes that were differentially expressed between older and younger people with sepsis and 
442 genes among older and healthy younger subjects.
Interestingly, oxidative phosphorylation pathways and mitochondrial dysfunction were the 
most altered in older people with sepsis compared with younger patients with sepsis. Other 
relevant pathways were signaling by TGF‐β, Wnt/β‐catenin, and calcium, as well as pathways 
that have been less studied in this disease, such as those involved in nerve growth factor and 
bone morphogenic protein.
Initially, our results confirmed that, regarding the production of TNF‐α, IL‐6, IL‐1β, TLRs, 
and other classical markers of cell activation, younger and older people respond similarly 
to a severe infectious insult. Some other pathways, as described above, appear to be more 
affected in older patients in a critical condition than in younger patients. We consider that 
defects of mitochondrial function and oxidative phosphorylation, and signaling by TGF‐β, 
Wnt/β‐catenin, bone morphogenic protein, nerve growth factor, and calcium are different in 
older patients with sepsis than in younger patients with sepsis.
Confirming our hypothesis, we observed a notable decrease in gene expression of the 
mitochondrial respiratory chain in older patients with sepsis [46]. Mitochondrial dysfunc‐
tion is known for contributing to multiple organ failure in sepsis. Physiologically, small 
amounts of reactive species of oxygen are produced by complex I and III of the respiratory 
chain. Sepsis is characterized by an increase in oxidative stress due to increased production 
of neutrophils, an increase in xanthine oxidase activity, increased plasma levels of nitric 
oxide, and decreased antioxidant capacity of plasma [47]. Pro‐inflammatory mediators and 
oxidative stress deregulate the function of respiratory chain enzymes and lead to structural 
damage of lipids, proteins, and mitochondrial DNA [48, 49], promoting failure of multiple 
organs [50]. Mitochondrial damage and secondary dysfunction to oxidative stress are also 
characteristic of the aging process [6, 51, 52]. Mice that have defective function of mito‐
chondrial DNA polymerase enzyme have a shorter life and show many signs of premature 
aging, such as alopecia, decreased physical activity, and early loss of reproductive function 
[53].
The mechanisms that lead to specific dysfunction of several signaling pathways in the 
immune response of older people are complex and involve multiple factors. We propose 
that environmental factors [54, 55], microRNAs [56], and epigenetic changes [57] play a 
major role in modulating the immune response cascades that are particularly affected in 
older patients.
Our data confirm previous reports that aging is accompanied by changes in gene expres‐
sion of immune system pathways [58]. Another important result of our research group shows 
that noncoding long RNA subgroups are deregulated in sepsis and during the aging process. 
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Therefore, extensive studies are required to investigate the biological role played by this class 
of transcripts in septic shock in older individuals.
4. Conclusion
There is great expectation that studying biological systems can provide a better understand‐
ing of several complex diseases. Further information could be used to identify new therapeu‐
tic targets and groups of patients who should benefit from such interventions.
Using this strategy, we have identified the main pathways that are altered in older people 
with sepsis. Our findings highlight that the systemic inflammatory response differs depend‐
ing on the population that is studied. Oxidative stress appears to play a central role, induc‐
ing various types of dysfunction, in older patients with sepsis. Moreover, we have identified 
several other genes and signaling pathways that are altered in these patients. This information 
will facilitate understanding of the nature of the immune response in this situation.
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